超声诊断的非酒精性脂肪性肝病独立预测非超重人群发生糖尿病的较高风险
这项回顾性队列研究纳入10064例体重指数<23 kg/m2的非超重者,用腹部超声诊断非酒精性脂肪性肝病(us-NAFLD),平均随访6.0年。us-NAFLD组糖尿病发生率为6.2%,无us-NAFLD组为1.0%;校正后风险比2.52(95%CI 1.58-4.03)。结论认为us-NAFLD对非超重人群发生糖尿病有独立预测价值。
要点
- 非超重人群us-NAFLD组糖尿病发生率6.2%,无us-NAFLD组1.0%。
- us-NAFLD预测糖尿病的校正HR为2.52(95%CI 1.58-4.03)。
- 代谢综合征预测糖尿病的校正HR为2.64(95%CI 1.54-4.54)。
核心结论
- 本研究显示,超声诊断的非酒精性脂肪性肝病对非超重人群发生糖尿病具有独立预测价值。
研究设计与样本
- 回顾性队列研究,纳入10064例体重指数<23 kg/m2的参与者,用腹部超声诊断us-NAFLD,并按us-NAFLD和代谢综合征的有无分组,平均随访6.0年。
关键影像表现/征象
- 腹部超声用于诊断非酒精性脂肪性肝病(us-NAFLD)。
诊断标准与关键数值
- us-NAFLD预测糖尿病的校正HR为2.52(95%CI 1.58-4.03)。
- 代谢综合征预测糖尿病的校正HR为2.64(95%CI 1.54-4.54)。
- 无us-NAFLD者糖尿病发生率为1.0%,有us-NAFLD者为6.2%。
- 无代谢综合征者糖尿病发生率为1.1%,有代谢综合征者为13.2%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: This study was aimed to evaluate the independent value of ultrasound-diagnosed nonalcoholic fatty liver disease (us-NAFLD), as a surrogate imaging marker of the pathologic entity of NAFLD, in predicting incident diabetes mellitus (DM) in nonoverweight individuals.
MATERIALS AND METHODS: A total of 10,064 participants who had a body mass index <23 kg/m2 were included in this retrospective cohort study. us-NAFLD was diagnosed using abdominal ultrasound. All participants were divided into subgroups according to the presence or absence of us-NAFLD and metabolic syndrome (MS).
RESULTS: Over a mean follow-up of 6.0 years, 125 participants (1.2%) developed DM. The incidence rates of DM were 1.0% in participants without us-NAFLD, 6.2% in participants with us-NAFLD, 1.1% in participants without MS, and 13.2% in participants with MS. The adjusted hazard ratios for incident DM were 2.52 (95% confidence interval:1.58-4.03) for us-NAFLD and 2.64 (95% confidence interval:1.54-4.54) for MS.
CONCLUSION: This study demonstrates that us-NAFLD has an independent value in predicting incident DM in non-overweight individuals.
引用
- Wang L. Ultrasound-Diagnosed Nonalcoholic Fatty Liver Disease Independently Predicts a Higher Risk of Developing Diabetes Mellitus in Nonoverweight Individuals. Acad Radiol. 2018. PMID: 30254005. doi:10.1016/j.acra.2018.08.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。